3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy

Publisher： Karger

E-ISSN： 1421-9824|21|5-6|353-363

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.21, Iss.5-6, 2006-05, pp. : 353-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cognitive Predictors of Donepezil Therapy Response in Alzheimer Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 1, 2007-05 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 3, 1999-05 ,pp. : 237-244

Karger

Access to resources Recommend Favorite

An Observational Clinical Study of the Efficacy and Tolerability of Donepezil in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 15, Iss. 4, 2003-03 ,pp. : 189-198

Karger

Access to resources Recommend Favorite

Donepezil for Alzheimer’s Disease in Clinical Practice – The DONALD Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 18, Iss. 1, 2004-06 ,pp. : 37-43

Karger

Access to resources Recommend Favorite

Treatment of a Whole Population Sample of Alzheimer’s Disease with Donepezil over a 4-Year Period: Lessons Learned

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 3, 2008-01 ,pp. : 226-231

Karger

Access to resources Recommend Favorite